Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

NCT04221256 is registered in ClinicalTrials.gov with Burke Medical Research Institute as lead sponsor.

NCT NCT04221256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity
Lead sponsor
Burke Medical Research Institute
Phase
Phase 1/2
Overall status
Withdrawn
Start date
March 11, 2020
Completion date
February 9, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic